Form 4: Inspire Medical Systems Director, Shawn McCormick, Reports Stock Transactions
SEC Form 4 Filing
Director Shawn McCormick reports acquisition of restricted stock units and sale of common stock in Inspire Medical Systems.
Summary
- Shawn McCormick, a director at Inspire Medical Systems, reported transactions involving the company's stock.
- On May 1, 2025, McCormick acquired 1,266 restricted stock units (RSUs) at a price of $0.
- These RSUs will vest on the first anniversary of the grant date or upon a change of control, contingent upon continued employment.
- On May 2, 2025, McCormick sold 360 shares of common stock at $160 per share.
- Following these transactions, McCormick directly owns 24,046 shares of common stock and indirectly owns 3,000 shares through a trust.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock transactions.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 2024-11-13 | Date of Rule 10b5-1 trading plan |
| 2025-05-01 | Acquisition of 1,266 Restricted Stock Units |
| 2025-05-02 | Sale of 360 shares of Common Stock at $160 |
| 2025-05-05 | Date of signature on the Form 4 filing |
Keywords
Form 4, Insider Trading, Stock Sale, Restricted Stock Units, INSP, Inspire Medical Systems, Shawn McCormick
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.